Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (41-50 of 301) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|April 16, 2017
Outpatient desensitization in selected patients with platinum hypersensitivity reactionsDavid M O'Malley, Monica Hagan Vetter, David E Cohn, et al.
Gynecologic Oncology|July 23, 2022
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerationsMonica D Levine, David A Barrington, Heather Hampel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysisDavid E Cohn, Kenneth H Kim, Kimberly E Resnick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2016
Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A SubanalysisCaroline C Billingsley, David E Cohn, David G Mutch, et al.
Gynecologic Oncology|July 26, 2022
Racial and ethnic disparities in readmission risk following the surgical management of endometrial cancerDavid A Barrington, Caitlin E Meade, Casey M Cosgrove, et al.
Lab on a Chip|September 8, 2018
Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomesColin L Hisey, Kalpana Deepa Priya Dorayappan, David E Cohn, et al.
Gynecologic Oncology|December 26, 2001
Ureteroileoneocystostomy: the use of an ileal segment for ureteral substitution in gynecologic oncologyTom P Manolitsas, Larry J Copeland, David E Cohn, et al.
Obstetrics and Gynecology|August 25, 2009
Lynch syndrome screening strategies among newly diagnosed endometrial cancer patientsKimberly Resnick, J Michael Straughn, Floor Backes, et al.
Journal of Oncology Practice|October 11, 2017
ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian CancerJonathan Foote, Angeles Alvarez Secord, Margaret Liang, et al.
Gynecologic Oncology|October 22, 2008
Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinomaKatherine V Schwab, David M O'Malley, Jeffrey M Fowler, et al.
Pageof 31

Showing results (41-50 of 301) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|April 16, 2017
Outpatient desensitization in selected patients with platinum hypersensitivity reactionsDavid M O'Malley, Monica Hagan Vetter, David E Cohn, et al.
Gynecologic Oncology|July 23, 2022
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerationsMonica D Levine, David A Barrington, Heather Hampel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysisDavid E Cohn, Kenneth H Kim, Kimberly E Resnick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2016
Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A SubanalysisCaroline C Billingsley, David E Cohn, David G Mutch, et al.
Gynecologic Oncology|July 26, 2022
Racial and ethnic disparities in readmission risk following the surgical management of endometrial cancerDavid A Barrington, Caitlin E Meade, Casey M Cosgrove, et al.
Lab on a Chip|September 8, 2018
Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomesColin L Hisey, Kalpana Deepa Priya Dorayappan, David E Cohn, et al.
Gynecologic Oncology|December 26, 2001
Ureteroileoneocystostomy: the use of an ileal segment for ureteral substitution in gynecologic oncologyTom P Manolitsas, Larry J Copeland, David E Cohn, et al.
Obstetrics and Gynecology|August 25, 2009
Lynch syndrome screening strategies among newly diagnosed endometrial cancer patientsKimberly Resnick, J Michael Straughn, Floor Backes, et al.
Journal of Oncology Practice|October 11, 2017
ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian CancerJonathan Foote, Angeles Alvarez Secord, Margaret Liang, et al.
Gynecologic Oncology|October 22, 2008
Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinomaKatherine V Schwab, David M O'Malley, Jeffrey M Fowler, et al.
Pageof 31